Autumn 2025 Newsletter

In This Issue:

• Leading the Next Generation of Discovery at the Easton Center
• Progress in Research: Highlights from AAIC 2025
• Updates from BEAM
• Clinical Trials
• Upcoming Events

The Mary S. Easton Center for Alzheimer’s Research and Care at UCLA has very active teams working on basic research, drug discovery, biomarkers for early diagnosis and clinical activity including clinical trials, cognitive testing, and patient care.

Leading the Next Generation of Discovery at the Easton Center

By: Jason Hinman, MD, PhD, Director of the Mary S. Easton Center for Alzheimer's Research and Care at UCLA

I am honored and delighted to serve as the next Director of the Mary S. Easton Center for Alzheimer’s Research and Care. Over the past decade, research inspired by the National Alzheimer’s Project Act (NAPA) has transformed how we diagnose and manage people at risk for or living with Alzheimer’s disease and related dementias. Newly approved FDA biomarkers and anti-amyloid therapies are opening the door to a new era in brain health. These advances demand fresh thinking—about how, when, and where we diagnose cognitive impairment, and how our health systems can adapt to deliver these emerging treatments. While they represent tremendous progress, we recognize that they are not a cure. Still, they crystallize a clearer path forward, one that I am eager to help shape in this new leadership role.

As Director, I am privileged to guide the work of an extraordinary group of professionals.

Continue reading the article.